Racial and ethnic disparities in cancers of the uterine corpus

Journal of the National Medical Association

Volumn 98, Issue 12, 2006, Pages 1930-1933

  Yap, O W Stephanie ^a,b   Matthews, Roland P ^a,b  

^a Morehouse School of Medicine ^*

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Health disparities; Minorities; Race ethnicity; Women's health

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER PREVENTION; CANCER RESEARCH; CANCER SCREENING; CANCER SURVIVAL; CANCER THERAPY; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; ENDOMETRIUM CANCER; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; HEALTH CARE; HEALTH SERVICE; HUMAN; MOLECULAR DYNAMICS; NEGRO; PATIENT CARE; PRIORITY JOURNAL; RACE; RACE DIFFERENCE; SKIN COLOR; TREATMENT RESPONSE; UTERUS CANCER;

AFRICAN AMERICANS; EARLY DIAGNOSIS; ENDOMETRIAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 33845657345     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. www.cancer.org/docroot/stt/stt_0.asp. Accessed 09/06/06.
2. http://seer.cancer.gov/csr/1975_2003/results_merged/sect_07_corpus_ uteri.pdf. Accessed 09/06/06.
3. Barrett RJ II, Harlan LC, Wesley MN, et al. Endometrial cancer: stage at diagnosis and associated factors in black and white patients. Am J Obstet Gynecol. 1995;173:414-422; discussion 422-423.
4. Hicks ML, Phillips JL, Parham G, et al. The National Cancer Data Base report on endometrial carcinoma in African-American women. Cancer. 1998;83:2629-2637.
5. Hill HA, Eley JW, Harlan LC, et al. Racial differences in endometrial cancer survival: the black/white cancer survival study. Obstet Gynecol. 1996;88:919-926.
6. Liu JR, Conaway M, Rodriguez GC, et al. Relationship between race and interval to treatment in endometrial cancer. Obstet Gynecol. 1995;86:486-490.
7. Matthews RP, Hutchinson-Colas, Maiman M, et al. Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women. Gynecol Oncol. 1997;65:206-212.
8. Madison T, Schottenfeld D, Baker V. Cancer of the corpus uteri in white and black women in Michigan, 1985-1994: an analysis of trends in incidence and mortality and their relation to histologic subtype and stage. Cancer. 1998;83:1546-1554.
9. Hicks ML, Kirn W, Abrams J, et al. Racial differences in surgically staged patients with endometrial cancer. J Natl Med Assoc. 1997;89:134-140.
10. Plaxe SC, Saltzstein SL. Impact of ethnicity on the incidence of high-risk endometrial carcinoma. Gynecol Oncol. 1997;65:8-12.
11. Sherman ME, Devesa SS. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer. 2003;98:176-186.
12. Connell PP, Rotmensch J, Waggoner SE, et al. Race and clinical outcome in endometrial carcinoma. Obstet Gynecol. 1999;94:713-720.
13. Trimble EL, Harlan LC, Clegg LX, et al. Pre-operative imaging, surgery and adjuvant therapy for women diagnosed with cancer of the corpus uteri in community practice in the United States. Gynecol Oncol. 2005;96:741-748.
14. Clifford SL, Kaminetsky CP, Cirisano FD, et al. Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer. Am J Obstet Gynecol. 1997;176:5229-5232.
15. Kohler MF, Carney P, Dodge R, et al. p53 overexpression in advanced-stage endometrial adenocarcinoma. Am J Obstet Gynecol. 1996;175:1246-1252.
16. Santin AD, Bellone S, Siegel ER, et al. Racial differences in the overexpression of epidermal growth factor type 11 receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer. Am J Obstet Gynecol. 2005;192:813-818.
17. Ito K, Watanabe K, Nasim S, et al. Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res. 1994;54:4667-4670.
18. Tashiro H, Isacson C, Levein R, et al. p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol. 1997;150:177-185.
19. Risinger JI, Hayes K, Maxwell GL, et al. PTEN mutations in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin Cancer Res. 1998;4:3005-3010.
20. Maxwell GL, Risinger JI, Hayes KA, et al. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers. Clin Cancer Res. 2000;6:2999-3005.
21. Risinger JI, Berchuck A, Kohler MF, et al. Genetic instability of microsatellites in endometrial cancer. Cancer Res. 1993;53:5100-5103.
22. Maxwell GL, Chandramouli GV, Dainty L, et al. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer. Clin Cancer Res. 2005;11:4056-4066.
23. Randall TC, Armstrong K. Differences in treatment and outcome between African-American and white women with endometrial cancer. J Clin Oncol. 2003;21:4200-4206.
24. Morgan MA, Behbakht, Benjamin I, et al. Racial differences in survival from gynecologic cancer. Obstet Gynecol. 1996;88:914-918.
25. Aziz H, Rotman M, Hussain F, et al. Poor survival of black patients in carcinoma of the endometrium. Inf J Radiat Oncol Biol Phys. 1993;27:293-301.
26. Maxwell GL, Tian C, Risinger JI, et al. Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group (GOG) study. Presented at the 2005 Annual Meeting of the Society of Gynecologic Oncologists, 2005: Abst#38.
27. Bain RP, Greenberg RS, Chung KC. Racial differences in survival of women with endometrial cancer. Am J Obstet Gynecol. 1987;157:914-923.
28. Kost ER, Hall KL, Hines JF, et al. Asian-Pacific Islander race independently predicts poor outcome in patients with endometrial cancer. Gynecol Oncol. 2003;89:218-226.